IRIS
ANDREOTTI, GIUSEPPINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.036
NA - Nord America 844
EU - Europa 616
SA - Sud America 119
AF - Africa 34
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 2.653
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 807
SG - Singapore 433
RU - Federazione Russa 325
VN - Vietnam 220
CN - Cina 203
IT - Italia 109
BR - Brasile 88
HK - Hong Kong 72
FR - Francia 51
DE - Germania 37
CA - Canada 22
NL - Olanda 22
JP - Giappone 21
CI - Costa d'Avorio 20
BD - Bangladesh 17
IN - India 15
GB - Regno Unito 14
AR - Argentina 13
KR - Corea 12
PL - Polonia 11
FI - Finlandia 10
AT - Austria 9
MX - Messico 9
IQ - Iraq 8
UA - Ucraina 6
EC - Ecuador 5
PH - Filippine 5
ZA - Sudafrica 5
ID - Indonesia 4
IE - Irlanda 4
KE - Kenya 4
PK - Pakistan 4
TW - Taiwan 4
CO - Colombia 3
ES - Italia 3
LT - Lituania 3
PY - Paraguay 3
UZ - Uzbekistan 3
VE - Venezuela 3
CL - Cile 2
EG - Egitto 2
HU - Ungheria 2
JM - Giamaica 2
JO - Giordania 2
LU - Lussemburgo 2
OM - Oman 2
PE - Perù 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BG - Bulgaria 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
GA - Gabon 1
GP - Guadalupe 1
IL - Israele 1
IR - Iran 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MA - Marocco 1
MQ - Martinica 1
PR - Porto Rico 1
QA - Qatar 1
RS - Serbia 1
SA - Arabia Saudita 1
SE - Svezia 1
TL - Timor Orientale 1
TR - Turchia 1
Totale 2.653
Salva come PNG Salva come JPEG
Città #
Singapore 223
San Jose 131
Ashburn 81
Moscow 78
Santa Clara 75
Hong Kong 70
Chandler 65
Hefei 61
Beijing 58
Ho Chi Minh City 50
Hanoi 48
Naples 31
The Dalles 24
Lauterbourg 21
Los Angeles 19
Tokyo 19
New York 16
Amsterdam 13
Millbury 13
Des Moines 12
Redondo Beach 12
Boston 11
Frankfurt am Main 11
Da Nang 10
Seoul 10
Buffalo 9
Dallas 9
Haiphong 9
Lappeenranta 9
Lawrence 9
Toronto 9
Chicago 8
Nuremberg 8
Rome 8
São Paulo 8
Biên Hòa 7
Council Bluffs 7
Gdansk 7
Munich 7
Orem 7
Paris 7
Wilmington 7
Mexico City 6
Nanjing 6
Falkenstein 5
London 5
Montreal 5
Baghdad 4
Berlin 4
Casavatore 4
Changsha 4
Denver 4
Dublin 4
Hải Dương 4
Innsbruck 4
Nha Trang 4
Princeton 4
San Francisco 4
Bauru 3
Boardman 3
Brasília 3
Brooklyn 3
Bình Phước 3
Columbus 3
Hebei 3
Houston 3
Jacksonville 3
Milan 3
Mumbai 3
Napoli 3
Sulaymaniyah 3
Tashkent 3
Tiggiano 3
Torre Annunziata 3
Trento 3
Vienna 3
Warsaw 3
Atlanta 2
Bacoli 2
Bangkok 2
Boydton 2
Budapest 2
Can Tho 2
Chennai 2
El Cajon 2
Fortaleza 2
Frisco 2
Goiânia 2
Guangzhou 2
Johannesburg 2
Joinville 2
Lima 2
Manchester 2
Nairobi 2
New Delhi 2
Ottawa 2
Petrópolis 2
Phoenix 2
Pittsburgh 2
Poplar 2
Totale 1.471
Salva come PNG Salva come JPEG
Nome #
A mutant of phosphomannomutase1 retains full enzymatic activity, but is not activated by IMP: Possible implications for the disease PMM2-CDG 149
Pharmacological chaperones: A therapeutic approach for diseases caused by destabilizing missense mutations 149
The Analysis of Variants in the General Population Reveals That PMM2 Is Extremely Tolerant to Missense Mutations and That Diagnosis of PMM2-CDG Can Benefit from the Identification of Modifiers 143
Enzyme Replacement Therapy for FABRY Disease: Possible Strategies to Improve Its Efficacy 140
Why does SARS-CoV-2 hit in different ways? Host genetic factors can influence the acquisition or the course of COVID-19 138
Protective role of a tmprss2 variant on severe covid-19 outcome in young males and elderly women 138
Drug Repositioning for Fabry Disease: Acetylsalicylic Acid Potentiates the Stabilization of Lysosomal Alpha-Galactosidase by Pharmacological Chaperones 134
D2A-Ala peptide derived from the urokinase receptor exerts anti-tumoural effects in vitro and in vivo 127
β-Glucose-1,6-Bisphosphate Stabilizes Pathological Phophomannomutase2 Mutants In Vitro and Represents a Lead Compound to Develop Pharmacological Chaperones for the Most Common Disorder of Glycosylation, PMM2-CDG 123
E-Learning for Rare Diseases: An Example Using Fabry Disease 120
Proteostasis regulators modulate proteasomal activity and gene expression to attenuate multiple phenotypes in Fabry disease 118
E-learning for marine biotechnology: an example with a metagenomic approach 117
Data on the inhibition of cell proliferation and invasion by the D2A-Ala peptide derived from the urokinase receptor 117
Curcumin Has Beneficial Effects on Lysosomal Alpha-Galactosidase: Potential Implications for the Cure of Fabry Disease 115
D2A sequence of the urokinase receptor induces cell growth through αvβ3 integrin and EGFR 107
Evolutionary rescue of phosphomannomutase deficiency in yeast models of human disease 106
PEGYLATION, THE ULTIMATE STRATEGY TO IMPROVE THE IN VIVO EFFICIENCY OF BIOACTIVE COMPOUNDS 106
Identification of trombospondin-1 as a novel amelogenin interactor by functional proteomics 104
Drug Repurposing and Lysosomal Storage Disorders: A Trick to Treat 104
Passenger mutations as a target for the personalized therapy of cancer 99
ReBaTSA: A simplified CeTSA protocol for studying recombinant mutant proteins in bacterial extracts 98
In Silico Analysis of Phosphomannomutase-2 Dimer Interface Stability and Heterodimerization with Phosphomannomutase-1 69
Bioinformatics-Driven Multi-Factorial Insight into α-Galactosidase Mutations 69
Lipo‐Glc‐1,6‐ P 2 : A Bioprecursor Prodrug for Phosphomannomutase‐2 Congenital Disorder of Glycosylation 18
Totale 2.708
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.446
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.446
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202271 6 0 9 0 0 0 4 2 1 0 17 32
2022/2023178 15 33 5 5 12 31 10 16 27 8 13 3
2023/2024125 7 23 15 4 7 11 3 24 0 2 18 11
2024/2025742 38 31 3 1 23 62 76 49 29 86 254 90
2025/20261.490 137 141 151 133 272 72 137 65 190 123 41 28
2026/202722 22 0 0 0 0 0 0 0 0 0 0 0
Totale 2.708